Correlation of clinical characteristics between patients with seasonal influenza and patients infected by the wild type or delta variant of Sars-CoV-2
Bibliographic Data
| ID | 22084342 |
|---|---|
| Authors | Jianguo Zhang (0000-0001-7057-2862, Jiangsu University), Xing Huang (0000-0003-4054-1381, Wuhan University), Zhimin Tao (0000-0002-9765-2720, Jiangsu University, corresponding author) |
| Year | 2022 |
| Volume | 10 |
| Pages | 981233-981233 |
| Publication date | 2022-08-18 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Public Health (JOURNAL) |
| Journal identifiers | ISSN: 2296-2565 • E-ISSN: 2296-2565 |
| Publisher | Frontiers Media SA (PUBLISHER • CH) |
| DOI | 10.3389/fpubh.2022.981233 |
| PMID | 36062112 |
| OpenAlex | W4292411523 |
| Language | EN |
| Citations received | 2 |
| References cited | 46 |
Background: We compared the clinical characteristics of the patients with COVID-19, infected by the wild type or delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in connection with those of patients with seasonal influenza, all in mild cases. Methods: We retrospectively studied 245 and 115 patients with mild COVID-19 infected by the wild type and the delta variant of SARS-CoV-2, respectively, with their demographic information, medical history, and laboratory data from hospital records, individually compared to 377 patients with mild seasonal influenza, before and after individual treatment. Results: Compared to the influenza cohort, the COVID-19 cohort or the COVID-19 delta variant cohort demonstrated younger median age, lower male ratio, and shorter duration from disease onset to hospitalization. Hypertension remained the top comorbidity among all cohorts. Based on patients' data upon hospitalization, the correlation of clinical characteristics between patients with influenza and those with the wild-type COVID-19 is greater than that between patients with influenza and those with the delta variant COVID-19. Individual treatment in each viral disease alleviated most hematological parameters, but some compromised biomarkers at the time of hospital discharge revealed persistent renal or myocardial impairment among patients with COVID-19 and influenza in recovery. Conclusion: Timely and proper treatment using broad-spectrum antibiotics and antiviral drugs could moderately alleviate the acute viremia and possible bacterial co-infection in patients with mild COVID-19 and influenza, followed by compromised recovery. To prepare for the flu season amid the COVID-19 pandemic, preventive and adequate immunizations of both flu and COVID-19 vaccines, as well as specific therapeutics to effectively reverse viral impairments, are in urgent need
Cohort · Comorbidity · Disease · Pandemic · Retrospective cohort study · Viremia · Virus · COVID-19 Clinical Research Studies · Medicine · Respiratory viral infections research · SARS-CoV-2 and COVID-19 Research · Immunology · Internal Medicine · Pediatrics
Status of Hypertension in China
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
Sars-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Male sex identified by global Covid-19 meta-analysis as a risk factor for death and ITU admission
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Omicron Sars-CoV-2 variant
Clinical Characteristics of Coronavirus Disease 2019 in China
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Clinical course and risk factors for mortality of adult inpatients with Covid-19 in Wuhan, China
A Novel Coronavirus from Patients with Pneumonia in China, 2019
| Citations per year | 0.67 |
|---|---|
| Citation span | 2023 - 2024 (2) |
| Highly cited | No |